Research shows glycemic control improves risk of adverse cardiovascular outcomes
Publish Date: 7/10/2012
Researchers who were part of a Swedish observational study found that diabetes patients who reduced their hemoglobin A1c levels by nearly one percentage point had a significantly decreased risk of cardiovascular death. At the American Diabetes Association annual meeting, the research team presented their findings that the absolute risk of a death from a cardiovascular cause was 9.9 events per 1,000 person-years in patients with decreasing HbA1c and 17.8 per 1,000 in those with stable or increasing HbA1c.1
The study was based on data from the Swedish National Diabetes Register that identified 18,035 patients with a baseline HbA1c between 7% and 8.9% who ranged in age from 30 to 75 years.1 Along with decreased mortality risk, the research also indicated that better glycemic control was also associated with risk reductions in fatal and nonfatal coronary heart events and in fatal/nonfatal cardiovascular disease events.
- ADA: Glycemic Control Reduces CV Risk. MedPage Today. http://www.medpagetoday.com/MeetingCoverage/ADA/33262. Accessed June 26, 2012.